Kukje Pharma Co Ltd (002720) - Total Liabilities

Latest as of September 2025: ₩84.80 Billion KRW ≈ $57.47 Million USD

Based on the latest financial reports, Kukje Pharma Co Ltd (002720) has total liabilities worth ₩84.80 Billion KRW (≈ $57.47 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Kukje Pharma Co Ltd generate cash to assess how effectively this company generates cash.

Kukje Pharma Co Ltd - Total Liabilities Trend (2011–2024)

This chart illustrates how Kukje Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Kukje Pharma Co Ltd (002720) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Kukje Pharma Co Ltd Competitors by Total Liabilities

The table below lists competitors of Kukje Pharma Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Amoeba SA PA:ALMIB	France	€20.64 Million
Redtone International Bhd KLSE:0032	Malaysia	RM135.88 Million
Everest Industries Limited NSE:EVERESTIND	India	Rs7.26 Billion
Catalyst Bancorp Inc NASDAQ:CLST	USA	$201.20 Million
Urja Global Limited NSE:URJA	India	Rs1.06 Billion
Wooree Bio Co.Ltd KQ:082850	Korea	₩500.57 Billion
Linc Limited NSE:LINC	India	Rs1.07 Billion

Liability Composition Analysis (2011–2024)

This chart breaks down Kukje Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Kukje Pharma Co Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.89	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.47	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Kukje Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Kukje Pharma Co Ltd (2011–2024)

The table below shows the annual total liabilities of Kukje Pharma Co Ltd from 2011 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩76.00 Billion ≈ $51.50 Million	-2.95%
2023-12-31	₩78.31 Billion ≈ $53.07 Million	+25.27%
2022-12-31	₩62.51 Billion ≈ $42.36 Million	-12.19%
2021-12-31	₩71.20 Billion ≈ $48.25 Million	-5.23%
2020-12-31	₩75.13 Billion ≈ $50.91 Million	+2.02%
2019-12-31	₩73.64 Billion ≈ $49.90 Million	+27.99%
2018-12-31	₩57.54 Billion ≈ $38.99 Million	-9.91%
2017-12-31	₩63.87 Billion ≈ $43.28 Million	+3.12%
2016-12-31	₩61.94 Billion ≈ $41.97 Million	-9.16%
2015-12-31	₩68.18 Billion ≈ $46.21 Million	+2.29%
2014-12-31	₩66.66 Billion ≈ $45.17 Million	+12.78%
2013-12-31	₩59.10 Billion ≈ $40.05 Million	-0.79%
2012-12-31	₩59.57 Billion ≈ $40.37 Million	-10.85%
2011-12-31	₩66.82 Billion ≈ $45.28 Million	--

About Kukje Pharma Co Ltd

KO:002720 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$65.00 Million

₩95.91 Billion KRW

Market Cap Rank

#20870 Global

#1279 in Korea

Share Price

₩4710.00

Change (1 day)

-1.46%

52-Week Range

₩4100.00 - ₩5230.00

All Time High

₩12612.03